Retinoblastoma: genes and variants
Explore variant evidence for Retinoblastoma across 1 analyzed protein (RB1). Linked ClinVar records include 33 pathogenic or likely pathogenic variants, 961 variants of uncertain significance and 165 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Retinoblastoma
RB1: Retinoblastoma-associated protein
It restrains E2F-dependent transcription and prevents inappropriate G1-to-S cell-cycle progression until proliferative signals are appropriate. Loss of function is a fundamental cancer-driving event, while germline pathogenic variants cause hereditary retinoblastoma and increase risk of additional tumors.
33 ClinVar pathogenic / likely pathogenic and 1,122 uncertain variants in RB1 have source records linked to Retinoblastoma. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): PTCH1 and MAX.
Where Retinoblastoma variants cluster
- RB1 Domain B (positions 640–771): 12 of 33 ClinVar pathogenic / likely pathogenic variants, 2.6× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Retinoblastoma
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| RB1 G449R | 449 | Domain A | Pathogenic / likely pathogenic (★★) |
| RB1 V654M | 654 | Domain B | Pathogenic / likely pathogenic (★★) |
| RB1 V654L | 654 | Domain B | Pathogenic / likely pathogenic (★★) |
| RB1 S127T | 127 | Pathogenic / likely pathogenic (★★) | |
| RB1 S127N | 127 | Pathogenic / likely pathogenic (★★) | |
| RB1 C706Y | 706 | Domain B | Pathogenic / likely pathogenic (★★) |
| RB1 S567L | 567 | Domain A | Pathogenic / likely pathogenic (★★) |
| RB1 S888N | 888 | Domain C | Pathogenic / likely pathogenic (★★) |
| RB1 R46K | 46 | Pathogenic / likely pathogenic (★★) | |
| RB1 D286G | 286 | Pathogenic / likely pathogenic (★★) | |
| RB1 K530R | 530 | Domain A | Pathogenic / likely pathogenic (★★) |
| RB1 Q444P | 444 | Domain A | Pathogenic / likely pathogenic (★) |
| RB1 G449E | 449 | Domain A | Pathogenic / likely pathogenic (★) |
| RB1 G449V | 449 | Domain A | Pathogenic / likely pathogenic (★) |
| RB1 S127I | 127 | Pathogenic / likely pathogenic (★) | |
| RB1 W195L | 195 | Pathogenic / likely pathogenic (★) | |
| RB1 L400P | 400 | Domain A | Pathogenic / likely pathogenic (★) |
| RB1 Q444H | 444 | Domain A | Pathogenic / likely pathogenic (★) |
| RB1 Q444L | 444 | Domain A | Pathogenic / likely pathogenic (★) |
| RB1 H483R | 483 | Domain A | Pathogenic / likely pathogenic (★) |
| RB1 L657P | 657 | Domain B | Pathogenic / likely pathogenic (★) |
| RB1 E287D | 287 | Pathogenic / likely pathogenic (★) | |
| RB1 L662P | 662 | Domain B | Pathogenic / likely pathogenic (★) |
| RB1 M695K | 695 | Domain B | Pathogenic / likely pathogenic (★) |
| RB1 Q702K | 702 | Domain B | Pathogenic / likely pathogenic (★) |
| RB1 F760S | 760 | Domain B | Pathogenic / likely pathogenic (★) |
| RB1 R775S | 775 | Domain C | Pathogenic / likely pathogenic (★) |
| RB1 S888T | 888 | Domain C | Pathogenic / likely pathogenic (★) |
| RB1 L218V | 218 | Pathogenic / likely pathogenic (★) | |
| RB1 E737D | 737 | Domain B | Pathogenic / likely pathogenic (★) |
| RB1 K643E | 643 | Domain B | Pathogenic / likely pathogenic |
| RB1 D701N | 701 | Domain B | Pathogenic / likely pathogenic |
| RB1 H733Y | 733 | Domain B | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Retinoblastoma
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| RB1 L400V | 400 | Domain A | Conflicting reports (★) | +6: in a 3D region that tolerates change poorly (3R); L400P at the same position is pathogenic; REVEL 0.846 |
| RB1 V654G | 654 | Domain B | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; V654M at the same position is pathogenic; REVEL 0.938 |
| RB1 H483L | 483 | Domain A | Uncertain (★) | +6: in a 3D region that tolerates change poorly (3R); H483R at the same position is pathogenic; REVEL 0.959 |
| RB1 V654A | 654 | Domain B | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; V654M at the same position is pathogenic; REVEL 0.875 |
Which prediction tools work for Retinoblastoma
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- EVE: 95 out of 100
- PolyPhen-2: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 88 out of 100
- MetaSVM: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 86 out of 100
- MetaLR: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 81 out of 100
- CATVariant: 81 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Retinoblastoma
- Urinary bladder cancer, also linked to RB1
- Non-small cell lung carcinoma, also linked to RB1
- Lung adenocarcinoma, also linked to RB1
- Hepatocellular carcinoma, also linked to RB1
- Bone osteosarcoma, also linked to RB1
- Hereditary retinoblastoma, also linked to RB1
Frequently asked questions
Which genes have records linked to Retinoblastoma?
This view contains 1 analyzed proteins: RB1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 33 pathogenic or likely pathogenic variants, 961 variants of uncertain significance and 165 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 4 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,224 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center